AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

ACSH

Published November 11, 2026

GLP-1 Microdosing: Smaller doses, bigger claims | ACSH

Read the full story at ACSH

By Chuck Dinerstein, MD, MBA — Nov 11, 2026. Related content: RFK Jr. Has Visions of the Therapeutic Use of Psychedelics Dancing in His Head.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelics